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Abstract
Genome-wide association studies (GWA studies or GWAS) investigate the relationships between
genetic variants such as single-nucleotide polymorphisms (SNPs) and individual traits. Recently, in-
corporating biological priors together with machine learning methods in GWA studies has attracted
increasing attention. However, in real-world, nucleotide-level bio-priors have not been well-studied
to date. Alternatively, studies at gene-level, for example, protein–protein interactions and pathways,
are more rigorous and legitimate, and it is potentially beneficial to utilize such gene-level priors in
GWAS. In this paper, we proposed a novel two-level structured sparse model, called Sparse Group
Lasso with Group-level Graph structure (SGLGG), for GWAS. It can be considered as a sparse group
Lasso along with a group-level graph Lasso. Essentially, SGLGG penalizes the nucleotide-level spar-
sity as well as takes advantages of gene-level priors (both gene groups and networks), to identifying
phenotype-associated risk SNPs. We employ the alternating direction method of multipliers algorithm
to optimize the proposed model. Our experiments on the Alzheimer’s Disease Neuroimaging Initiative
whole genome sequence data and neuroimage data demonstrate the effectiveness of SGLGG. As a re-
gression model, it is competitive to the state-of-the-arts sparse models; as a variable selection method,
SGLGG is promising for identifying Alzheimer’s disease-related risk SNPs.
1 Introduction
Genetic variation is what makes us all unique. It refers to the diversity in the DNA sequence in hu-
man genomes and it may affect how an individual develops a disease or and responds to drugs, vaccines,
pathogens, and etc [5, 2]. The most common type of genetic variation is a single-nucleotide polymor-
phism (SNP)—i.e., a difference in a single nucleotide in the deoxyribonucleic acid (DNA) [13]. In the
past decade, genome-wide association studies (GWA studies or GWAS), which aim at revealing the re-
lationships between genetic variants such as SNPs and individual traits, have attracted much attention
achieved considerable success [14, 25, 28].
Traditional GWA studies are based on statistical tests. Genetic risk factors are determined by their
statistical significance, where a general procedure is to perform a statistical test between each individual
SNP and the phenotype under investigation [29, 8, 7]. For example, via meta-analyses, 11 new suscep-
tibility SNPs for Alzheimer’s disease (AD) have been identified [15]; 10 loci that may influence allergic
sensitization have been detected [3]. However, such kind of approaches has several limitations. First, it
ignores the aggregate effects of multiple SNPs, for example, the epistatic interactions between loci [34, 17].
Second, independent SNP–phenotype testing disregards the SNPs’ structural correlations associated with
population genetics (i.e., linkage disequilibrium, LD) and biological relations (e.g. functional relationships
between genes) [20].
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Later, increasing attention has been focused on Lasso (least absolute shrinkage and selection operator
[24]), as an alternative tool for identifying risk SNPs in GWAS [31, 26]. Lasso is a multivariate method that
models multiple SNPs simultaneously and highly precarious SNPs (that related to the phenotype under
investigation) can be identified through the non-zero components of the model. For example, a previous
whole genome association study [31] shows Lasso together with stability selection [19] is promising in
detecting risk SNPs associated with Alzheimer’s disease (AD) . However, there are two major drawbacks
of Lasso: 1) it tends to arbitrary select only one from a set of highly correlated features [10]; 2) it considers
all features equally without any further structural assumptions. To address the above issues, utilizing
structured sparse models together with different biological priors has aroused growing concern in GWAS,
as incorporating such assumptions is favorable for model construction and interpretation [32]. There are
several attempts, for example, group Lasso [18], tree Lasso [26], and absolute fused Lasso [30].
It is worth mentioning that all those aforementioned approaches are based on the nucleotide-level bio-
logical assumptions (e.g. LD or the consistency of successive SNPs). However, in real-world, at nucleotide-
level, neither structural associations, nor functional relationships, nor interaction mechanisms, have been
well-studied to date. On the other hand, studies of biological mechanisms are more rigorous and legitimate
at gene-level. For example, GeneMANIA [27] is a powerful tool for revealing gene-level biological net-
works. It integrates a large set of functional association data, including protein and genetic interactions,
pathways, co-expression, co-localization and protein domain similarity. As a consequence, it is potentially
beneficial to utilize such gene-level priors in nucleotide-level GWAS studies.
In this paper, we propose a novel two-level structured sparse model, called Sparse Group Lasso with
Group-level Graph structure (SGLGG), which a is promising method for identifying significant SNP–
phenotype associations. As its name indicates, SGLGG can be considered as a fusion model of a sparse
group Lasso [33, 9] and a group-level graph Lasso (a.k.a., graph-guided fused Lasso [6]). Essentially, our
proposed model involves two levels of predictors—i.e., the nucleotide-level predictors and the gene-level
predictors. And consequently in a GWA study, SGLGG will penalize the following three respects:
1. the gene-level sparsity;
2. the graph structure among gene-level predictors;
3. the nucleotide-level sparsity.
As a result, SGLGG tends to select only a set of causal SNPs within a gene group and limited gene
groups among the entire sequence. Meanwhile, it is capable of taking advantages of biological priors
(i.e., gene networks) during the gene-level selection. With the graph constraint, highly relevant genes
are likely to be chosen simultaneously, and thus SNPs from different gene scopes are potentially able
to connect. SGLGG is hard to solve due to its complex sparse-inducing regularizers. To this end,
we first transfer the edge constraints among the graph into the matrix form, and then, employ the
ADMM (alternating direction method of multipliers [4]) algorithm for optimizing. Experiments have been
conducted on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) whole genome sequence (WGS)
data and neuroimage data, for both regression tasks and variable selection tasks. Preliminary results
show that SGLGG is competitive to the state-of-the-arts sparse models in predicting AD-related imaging
phenotypes. In addition, stability selection results demonstrate that SGLGG is promising for identifying
risk SNPs associated with Alzheimer’s disease.
2 Our Model: SGLGG
Essentially, we consider a linear prediction model. Given a centered data matrix A ∈ Rn×p with n
observations and p features, and a corresponding response y ∈ Rn. Suppose that p predictors can be
divided intoK non-overlapping groups, with pk the number of low-level predictors in group k. Accordingly,
we denote s ∈ Rp be the low-level predictors and g ∈ RK be the group-level predictors, respectively.
Then, the low-level predictor s can be represented as s = [s11 . . . s1p1 . . . sk1 . . . skpk ]. We further denote
Gs = (M
Tg) ◦ s = [g1s11 g1s12 . . . g1s1p1 g2s21 g2s22 . . . g2s2p2 . . . gkskpk ] ∈ Rp, where ◦ is the Hadamard
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product operator, M ∈ Rk×p is a designed mapping matrix1, and gi, i ∈ [1, k] is the i-th element of g.
The group-level graph2 information is described by G ≡ (sK , E), where sK = {1, 2, . . . , k} is a set of
nodes, and E is the set of edges. In addition, let wg ∈ RK denote the weight vector corresponding to
the group-level predictors, and rij denote the weight of the edge between node gi and gj . Hence, in this
paper, we consider the following optimization problem:
min
g,s
{
`(y,Gs) + λ1‖wg ◦ g‖1 + λ2
∑
(i,j)∈E
τ(rij)|gi − sgn(rij)gj |+ λ3‖s‖1
}
, (1)
where `(·) is a convex empirical loss function (e.g. the least squares) and the error is calculated based on
Gs—a combination of predictors g and s via M; λ1, λ2, λ3 ≥ 0; and τ(rij) represent a general monotoni-
cally increasing function weight function that enforces a fusion effect between coefficients gi and gj .
In Eq. (1), the first constraint can be considered as a group-level sparsity constraint, the second con-
straint introduces the group-level graph structure via the fused Lasso, and the third constraint penalizes
the low-level sparsity. Hereby, we call Problem (1), the Sparse Group Lasso with Group-level Graph struc-
ture (SGLGG) problem. More specifically, in a GAW study, s represents the nucleotide-level predictor,
and accordingly, g can be considered as the gene-level predictor. Therefore, an ideal solution to Eq. (1)
will lead to the following scenarios: 1) only limited gene groups will be selected among the entire sequence;
2) the group selection is guided by the gene-level biological priors—i.e., relevant genes are more likely
to be chosen simultaneously; and 3) only a subset of SNPs will be selected within a selected gene. In
other words, the gene-level and nucleotide-level constraints ensure that the most relevant gene groups and
SNPs within a gene will be chosen by the model. Meanwhile, the group selection will be affected by the
gene-level priors—i.e., some inter-gene SNP–SNP connections could be revealed by the graph constraint.
Furthermore, the grpah constriant in Eq. (1) can be reformualted into a matrix form. Denote T be
the sparse matrix constructed from the edge set E, where tij = tji = rij if there is a edge between gi
and gj . Furthermore, for discussion convenience, we ignore the weight vectors in Eq. (1), then SGLGG
problem can be simplified as the following matrix form:
min
g,s
`(y,Gs) + λ1‖g‖1 + λ2‖Tg‖1 + λ3‖s‖1. (2)
3 ADMM for Solving SGLGG
3.1 ADMM basic
Due to the complex sparse-inducing regularizers, unconstrianted optimzation problem like (1) are some-
times hard to solve directly. Instead, it is possbile to reformulate the original unconstrianted problem
to an equivalent constrained problem. In the sequel, such a problem can be addressed using constrained
optimization methods such as the augmented Lagrangian method.
Hereby, we employ the alternating direction method of multipliers (ADMM) [4, 21] algorithm to solve
Problem (1). ADMM is a variant of the augmented Lagrangian method. It utilizes dual decomposition
and partial updates for the dual variables. Without loss of generality, we consider the following constraint
optimization problem:
min
x,z
f(x) + g(z) (3)
s.t. Ax+Bz = c,
where f and g are convex, x ∈ Rp, z ∈ Rq, A ∈ Rn×p, B ∈ Rn×q, and c ∈ Rn. With ADMM, we first
reformulate the above problem (3) as:
Lρ(x, z, µ) = f(x) + g(z) + µ
T (Ax+Bz− c) + ρ
2
‖Ax+Bz− c‖2, (4)
1M ∈ Rk×p is a binary matrix, an element mij = 1 if sj in group gi.
2In this study, we only consider the situation of undirected graph among group-level features.
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with µ being the augmented Lagrangian multiplier, and ρ being the non-negative dual update step length.
ADMM solves this problem by iteratively minimizing Lρ(x, z, µ) over x, z and µ, one at a time, until
convergence. Consequently, the update rule for ADMM is given by
xk+1 := arg min
x
Lρ(x, z
k, µk),
zk+1 := arg min
z
Lρ(x
k+1, z, µk),
µk+1 := µk + ρ(Axk+1 +Bzk+1 − c).
3.2 ADMM for solving SGLGG problem
Suppose `(·) be the least squares loss, then the SGLGG problem presented in (2) can be rewritten as the
following constrained form:
min
g,s,p,q,r
1
2
‖y −AGs‖2 + λ1‖p‖1 + λ2‖q‖1 + λ3‖r‖1 (5)
s.t. g − p = 0,Tg − q = 0, s− r = 0,
where p,q, r are slack variables. We employ ADMM to solve Problem (5). The augmented Lagrangian is
Lρ(g, s,p,q, r, µ, ν, ξ) =
1
2
‖y −AGs‖2+λ1‖p‖1 + λ2‖q‖1 + λ3‖r‖1+ (6)
µT (g − p) + νT (Tg − q) + ξT (s− r)+
ρ
2
‖g − p‖2 + ρ
2
‖Tg − q‖2 + ρ
2
‖s− r‖2,
where µ, ν, ξ are augmented Lagrangian multipliers. Accordingly, in the (k + 1)-th iteration, the update
rules are as follows:
• Update g: gk+1 can be updated by minimizing Lρ with s,p,q, r, µ, ν, ξ fixed:
gk+1 = arg min
g
1
2
‖y −A[(MTg) ◦ sk]‖2 + (µk +TT νk)Tg + ρ
2
‖g − pk‖2 + ρ
2
‖Tg − qk‖2
= arg min
g
1
2
‖y −ADiag(sk)MTg‖2 + [(µk +TT νk)T − ρpk − ρTTqk]g + ρ
2
gT (I+TTT)g
= arg min
g
1
2
gT [(Bk)TBk + ρ(I+TTT)]g − [yTBk − (µk +TT νk)T + ρ(pk)T + ρ(qk)TT]g
where Bk = ADiag(sk)MT , and Diag(·) is an operation that transforms a vector into a square
diagonal matrix. The above optimization problem is quadratic, and thus the optimal solution can
be obtained by solving the following linear system:
Fkgg
k+1 = bkg , (7)
where
Fkg = (B
k)TBk + ρ(I+TTT),
bkg = (B
k)Ty − µk −TT νk + ρpk + ρTTqk.
It is trivial to show that Fkg is symmetric positive definite (SPD), and thus Eq. (7) can be solved
efficiently via the conjugate gradient method [11] .
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• Update s: sk+1 can be updated by minimizing Lρ with g,p,q, r, µ, ν, ξ fixed:
sk+1 = arg min
s
1
2
‖y −A[(MTgk+1) ◦ s]‖2 + (ξk)T s+ ρ
2
‖s− rk‖2
= arg min
s
1
2
‖y −ADiag(MTgk+1)s‖2 + (ξk)T s+ ρ
2
‖s− rk‖2
= arg min
s
1
2
sT [(Ck)TCk + ρI]s− [yTCk − (ξk)T + ρ(rk)T ]s,
where Ck = ADiag(MTgk+1). Similar to the update rule of g, the above optimization problem is
quadratic, and thus the optimal solution can be obtained by solving the following linear system:
Fkss
k+1 = bks , (8)
where
Fks = C
TC+ ρI,
bks = C
Ty − ξk + ρrk.
Similarly, since Fks is SPD, Eq. (8) can be solved efficiently via the conjugate gradient method.
• Update p: Similarly, pk+1 can be obtained by solving the following problem:
pk+1 = arg min
p
λ1‖p‖1 + (µk)T (gk+1 − p) + ρ
2
‖gk+1 − p‖2
= arg min
p
λ1‖p‖1 − (µk)Tp+ ρ
2
‖gk+1 − p‖2
= arg min
p
1
2
‖p− (gk+1 + 1
ρ
µk)‖2 + λ1
ρ
‖p‖1
The above optimization problem has a closed-firm solution, known as the soft-thresholding :
pk+1 = Sλ1/ρ(g
k+1 +
1
ρ
µk), (9)
where the soft-thresholding operator is defined as:
Sλ(x) = sgn(x) max (|x| − λ, 0).
• Update q: Similarly, qk+1 can be obtained by solving the following problem:
qk+1 = arg min
q
λ2‖q‖1 + (νk)T (Tgk+1 − q) + ρ
2
‖Tgk+1 − q‖2.
The closed-form solution of the above problem can be obtained by:
qk+1 = Sλ2/ρ(Tg
k+1 +
1
ρ
νk). (10)
• Update r: Similarly, rk+1 can be obtained by solving the following problem:
rk+1 = arg min
r
λ3‖r‖1 + (ξk)T (sk+1 − r) + ρ
2
‖sk+1 − r‖2.
The closed-form solution of the above problem can be obtained by:
rk+1 = Sλ3/ρ(s
k+1 +
1
ρ
ξk). (11)
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• Update µ, ν, ξ: In the (k + 1)-th iteration, µ, ν, ξ are updated by:
µk+1 = µk + ρ(gk+1 − pk+1), (12)
νk+1 = νk + ρ(Tgk+1 − qk+1), (13)
ξk+1 = ξk + ρ(sk+1 − rk+1). (14)
We summarize the ADMM algorithm for solving the SGLGG Problem (2) in Algorithm 1. Generally,
ADMM breaks the original complex optimization problem into a series of smaller subproblems, each of
which is then easier to handle. In addition, it is worth mentioning that in practice, it is important to
normalize gi according to its group size.
Algorithm 1 ADMM for the sgLasso gGraph Problem
Input: A,y, E, λ1, λ2, λ3, ρ
Output: g, s
1: Initialization: Initialize g and s, k ← 0.
2: while not converge do
3: Update gk+1 according to Eq. (7).
4: Update sk+1 according to Eq. (8).
5: Update pk+1 according to Eq. (9).
6: Update qk+1 according to Eq. (10).
7: Update rk+1 according to Eq. (11).
8: Update µk+1, νk+1 and ξk+1 according to Eqs, respectively. (12), (13) & (14).
9: end while
4 Experiments
To evaluate the performance of the proposed SGLGG approach in GWAS, we conducted a series of
experiments on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) whole genome sequence (WGS)
data and neuroimage data. Particularly, we focus on two learning tasks: 1) predicting AD-related imaging
phenotypes (based on SNPs data); and 2) identifying risk SNPs w.r.t. AD imaging phenotypes.
4.1 Data processing
4.1.1 ADNI WGS data and neuroimaging data
In this study, we adopt the ADNI WGS data set and MRI data for GWAS. More specifically, the following
procedures have been employed for processing SNPs data. First, we employ PLINK [22] together with
a series of standard quality control constraints for SNPs data preprocessing. Particularly, a SNP will
be removed if its minor allele frequency (MAF) < 5%, or missingness > 5%, or deviations from Hardy-
Weinberg Equilibrium P < 5×10−7. In the sequel, we adopt MaCH [16] for genotype imputation. MaCH
is a Markov chain based haplotyper that is capable of resolving long haplotypes or inferring missing
genotypes. Eventually, we apply several filters on the imputed data set, including: RSQ (estimated R2,
specific to each SNP) > 0.5, FREQ1 (frequency for reference Allele 1) > 1% and FREQ1 < 99%. As
a consequence, the entire genome data contains 1,319 subjects with 6,566,154 SNPs, in which 155,357
SNPs are from Chromosome 19. For subjects composition, there are 327 healthy controls (HC), 249 AD
patients, 41 participants with mild cognitive impairment (MCI), 220 early MCI (EMCI) patients, 419 late
MCI (LMCI) patients, and 63 patients with significant memory concerns (SMC).
Volumes of some major influenced brain regions that are related to Alzheimer’s disease, including the
hippocampus (HIPP) and the entorhinal cortex (EC), have been chosen as the neuroimaging phenotypes
in this study. Those volumes were extracted from subject’s T1 MRI data using Freesurfer [23],
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4.1.2 Candidate AD genes
Hereby, we focus on Alzheimer’s disease genetic risk factors (at both gene-level and nucleotide-level) on the
19th chromosome of the human genome. Particularly, at gene-level, ten candidate genes are pre-selected as
high AD-risk according to AlzGene [1], including LDLR, GAPDHS, BCAM, PVRL2, TOMM40, APOE,
APOC1, APOC4, EXOC3L2, and CD33. Positions of those pre-selected genes are shown in Figure 1.
The above ten genes have been considered as the most strongly associated genes with AD on Chromo-
some 19 (Chr.19). In AlzGene, top associated genes are ranked based on genetic variants with the best
overall HuGENet/Venice grades [12]. Specifically, for genes with identical grades, the ranking is based on
their p-values; for genes with identical grades & p-values, the ranking is based on their effect sizes. Basic
information on those AD-risk genes is available in Table 1 (top part).
Figure 1: AD-risk genes (marked by yellow) on Chr.19 according to AlzGene.
Figure adapted from: http://www.alzgene.org/chromo.asp?c=19
4.1.3 Gene networks
To retrieve gene-level biological priors—i.e., gene networks, we utilized GeneMANIA [27] in our study.
Essentially, GeneMANIA is a powerful tool to extract gene networks based on a set of input genes. The
network is retrieved from a large set of functional association data, including gene co-expression & co-
localization, protein-protein interaction, genetic interaction, shared protein domains, pathway, and etc.
GeneMANIA stands for the Multiple Association Network Integration Algorithm. It consists of a linear
regression-based algorithm for calculating the functional association network and a label propagation
algorithm for predicting gene functions hereafter. In our study, we employ the following two methods to
extract gene networks.
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Table 1: Basic information of selected genes
Symbol Assembly Chr Location # of loci3
A
D
C
a
n
d
id
at
e
G
en
es
LDLR GRCh37.p13 19 11200037..11244506 135
GAPDHS GRCh37.p13 19 36024314..36036221 22
BCAM GRCh37.p13 19 45312316..45324678 15
PVRL2 GRCh37.p13 19 45349393..45392485 164
TOMM40 GRCh37.p13 19 45394477..45406946 38
APOE GRCh37.p13 19 45409039..45412650 5
APOC1 GRCh37.p13 19 45417577..45422606 14
APOC4 GRCh37.p13 19 45445495..45448753 7
EXOC3L2 GRCh37.p13 19 45715879..45737469 88
CD33 GRCh37.p13 19 51728335..51743274 16
A
ss
o
ci
a
te
d
G
en
es
LDLRAP1 GRCh37.p13 1 25870071..25895377 28
PVRL3 GRCh37.p13 3 110790606..110913017 73
APOA5 GRCh37.p13 11 116660086..116663136 7
APOA1 GRCh37.p13 11 116706467..116708338 5
CRTAM GRCh37.p13 11 122709255..122743347 75
GAPDH GRCh37.p13 12 6643585..6647537 10
LIPC GRCh37.p13 15 58702953..58861073 481
CD226 GRCh37.p13 18 67530192..67624412 149
APOC2 GRCh37.p13 19 45449239..45452822 17
SOD1 GRCh37.p13 21 33031935..33041244 15
1. Gene network within 10 pre-selected AD-risk genes in Chr.19.
Ten aforementioned AD-risk genes on Chromosome 19 are utilized as the input genes for GeneMA-
NIA. For network exploration, we only focus on connections within those ten pre-selected genes. In
addition, we adopt the biological process-based method for gene ontology weighting. A visualization
of this gene networks is shown in Figure 2 (left).
2. Extended gene network based on 10 selected Chr19 AD-related genes.
Similar to 1, but we allow to introduce ten additional genes for network exploration. This results
in totally 20 genes in the graph. A visualization of such a network is shown in Figure 2 (right).
Note that, additional genes are selected based on their relations with input genes and thus those
genes are not necessary located on Chromosome 19. Additional information of those selected genes
is available in Table 1 (bottom part).
Later, the experimental data sets were generated through those two aforementioned methods. More
specifically, we first construct a smaller SNPs data set that consists of SNPs from 10 pre-selected AD-risk
genes on Chromosome 19. As a result, such a data set contains 1,381 subjects and 504 SNPs. Next, we
generate a larger SNPs data set based on an extended gene network obtained through GeneMANIA—i.e.,
SNPs from 10 additional genes (as shown in Table 1) are also involved, according to gene-level associations.
Accordingly, the larger SNPs data set contains 1,364 SNPs in total from 20 candidate genes.
4.2 Learning task I — Predicting AD-related phenotypes
In the first series of experiments, we evaluate our proposed SGLGG model in a set of regression tasks—
i.e., predicting Alzheimer’s disease-related imaging phenotypes. More specifically, SGLGG is compared
with a suite of well-known commonly-used (structured) sparse methods, including Lasso, the fused Lasso
(FL) and sparse group Lasso (SGL). For SGL and SGLGG, SNPs in the same gene naturally fall into
a group. In addition, we compare SGLGG with the absolute fused Lasso (AFL) [30]—a novel learning
3This is the number of available loci in our experimental dataset.
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Figure 2: Visualizations of two gene networks. Left: network within 10 pre-selected AD-risk genes on
Chr.19; Right: extended gene network based on 10 pre-selected Chr.19 AD-risk genes.
model that penalizes SNPs successive similarities. Four imaging phenotypes including volumes of the left
entorhinal cortex (LEH), left hippocampus (LHP), right entorhinal cortex (REH), and right hippocampus
(RHP), are used as the responses in this study.
Experiments have been conducted on the two SNPs data sets described in Section 4.1.3. We adopt five-
fold cross-validation for each learning task and each sparse model. Comparisons of predictive performance
in terms of mean squared error (MSE) of 10 replications are shown in Figure 3 through box plots. In
Figure 3, each color represents a modeling method. Labels of the y-axis are named as follows: the first
few letters represent a modeling method, the middle three letters indicate the learning task, and the last
number (10 or 20) indicate the data set involved.
From Figure 3, we can observe that our proposed SGLGG model is very competitive compared with
other (structured) sparse models. With complex sparse-inducing regularizers and complex bio-priors,
SGLGG can still provide favorable predictive performance in most of the cases. Meanwhile, such a model
has better interpretability than traditional ones, as it incorporated extensive prior knowledge during
model learning. Therefore, it is potentially beneficial to address real-world GWA studies through the
SGLGG model.
4.3 Learning task II — Identifying AD-risk SNPs
One of the benefits of adopting a sparse model for GWAS is that the most relevant genetic factors
can be identified through the non-zero components from the model. Hereby, in the following series of
experiments, we compare the variable selection (i.e., SNPs selection) results of different structured sparse
methods through stability selection [19]. More specifically, experiments were conducted on the smaller
SNPs data set mentioned in Sec 4.1.3. We perform 100 simulations for each learning target. Within
each simulation, we first randomly subsample half of the subjects and then perform a modeling method
100 times with different regularization parameters (or pairs of parameters). The model selection results
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Figure 3: Comparison of regression error in terms of MSE of different structured sparse models on can-
didate AD-risk genes on Chr.19. For y-axis labels: the first few letters represent a modeling
method, the middle three letters indicate the learning task, and the last number (10 or 20)
indicate the data set involved.
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are visualized in Figure 4. Detailed SNPs selection results are available in Appendix 1. In Figure 4,
top 50 selected SNPs are marked for each method; each color refers to a modeling method; the x-axis
is a compact illustration of gene/SNPs location on Chromosome 19; green bars together with the y-axis
indicate the negative logarithmic of P-values of SNPs associated with each learning task.
From Figure 4, we have the following observations:
1. SNPs selected by Lasso and SGL are spread over a large region in the feature sets (i.e., across
different genes). However, most SNPs selected by FL, AFL, and our proposed SGLGG model are
clustered in a few small regions.
2. SNPs groups identified by SGLGG are different from FL or AFL, where the proposed method tends
to select more SNPs within a gene but fewer number of genes in total.
3. Statistical significance in terms of P-value of an SNP selected by SGLGG, may not necessarily be
small4 (see the bottom two sub-figures in Figure 4).
The above observations imply that our proposed SGLGG model sparse selection on both nucleotide-
level and gene-level. Within a gene, only the most relevant SNPs will be chosen. The group selection is
benefited from gene-level biological prior knowledge—i.e., gene network. Thus, potential inter-gene SNP–
SNP connections could be established by SGLGG. In other words, SGLGG is a promising method and
has good prospects in revealing the causal SNPs that associated with a phenotype under investigation.
5 Conclusion
In this paper, we proposed a novel two-level structured sparse model—SGLGG—for genome-wide asso-
ciation studies. Essentially, it can be considered as a sparse group Lasso together with a group-level
graph-guided fused Lasso. Specifically, SGLGG induces sparsities in both nucleotide-level and gene-level.
That is, only the most causal SNPs will be selected within a gene group and only a part of relevant
genes will be chosen on the genome. Another benefit of SGLGG is that it also takes advantages of
gene-level biological priors during the model construction. Consequently, gene-level bio-priors such as
protein–protein interactions and pathways can be utilized to explore inter-gene SNP–SNP connections.
To address SGLGG model, we propose an ADMM-based optimization algorithm. Our experiments on the
Alzheimer’s disease genome sequence data and neuroimaging data show that SGLGG is very competitive
in predict AD-related phenotypes, compared with other state-of-the-arts sparse learning models. Further-
more, stability selection results demonstrate that SGLGG is a promising model for identifying AD-risk
SNPs. With the help of gene-level biological priors, SGLGG has good prospects for revealing SNP–SNP
interactions among different genes.
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Figure 4: Comparison of stability selection results of different structured sparse models on Chromosome 19. Each subfigure refers to an AD-
related neuroimaging phenotype, specifically, upper left—LEH; bottom left—LHP; upper right—REH; bottom right—RHP. The
x-axis is a compact illustration of gene/SNP positions on Chr.19. The y-axis is the negative logarithm of P-value of SNPs regarding
the phenotype under investigation. For each learning task, top 50 selected SNPs of each model are marked out.
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Appendix 1: Variable selection results of different learning targets
Table 2: Comparison of top 50 selected SNPs associated with different sparse models and neuroimage targets on the 10 AD-related genes on
Chr.19. SNPs are sorted by their positions on the chromosome. Selection results are marked by different colors for different models. The
negative logarithm of P-values is shown on the right side of each response. SNPs are ignored if they are not in the top selected list of any traits.
Model reference: L—Lasso; fL—fused Lasso; sgL—sparse group Lasso; afL—absolute fused Lasso; our—SGLGG.
Target LEH LHP REH RHP
Gene Locus/SNP L fL sgL afL our -log(P) L fL sgL afL our -log(P) L fL sgL afL our -log(P) L fL sgL afL our -log(P)
LDLR
(58/135)
rs12981050 0.7899 0.7739 0.1724 0.8356
rs57217136 0.3490 0.4339 0.5000 0.0073
19:11201988 0.3486 0.4326 0.5004 0.0066
19:11202194 0.3415 0.4172 0.5083 0.0007
rs6511720 0.3376 0.4080 0.5127 0.0053
rs17242367 1.0509 0.6456 0.0168 1.1834
rs6511721 2.1718 2.0580 0.5733 1.8577
rs17248769 1.2221 1.4125 0.5339 1.0289
rs73015033 1.2915 1.4698 0.5982 1.0884
19:11209669 1.1741 1.4337 0.5822 1.0432
rs73015034 1.2951 1.4728 0.6028 1.0910
19:11209757 1.2972 1.4749 0.6051 1.0929
rs74857287 1.2992 1.4768 0.6068 1.0946
rs17248776 1.3039 1.4794 0.6098 1.0980
rs17248783 1.3586 1.5249 0.6629 1.1474
rs2228671 1.3720 1.5250 0.6681 1.1210
rs36096887 0.5588 0.6581 0.5592 1.7026
rs12983082 0.4876 1.3053 0.0132 1.8414
rs10422256 0.9677 2.0577 0.0811 2.7542
rs892116 0.3880 1.4702 0.4698 2.4707
rs12710260 0.5528 1.5892 0.0134 1.8819
19:11223683 0.0027 0.1174 1.4241 0.0745
rs9789328 0.5740 1.9552 0.0467 2.1195
rs2738445 0.5148 1.8265 0.5569 2.7873
rs2738446 0.5362 1.9059 0.0649 2.0939
rs1799898 1.1926 0.7147 0.5502 1.9748
rs28786710 0.5551 1.8321 0.1645 2.0467
19:11228620 0.9978 1.8387 1.1850 0.0004
rs2738448 0.5506 1.8251 0.1691 2.0366
rs2569550 0.1932 1.5543 0.7497 2.6723
rs2738449 0.5585 1.8219 0.1763 2.0355
rs2738450 0.5440 1.8163 0.1751 2.0242
rs2738452 0.5423 1.8135 0.1769 2.0201
rs12611153 1.4321 0.6694 2.0399 0.7019
rs2569546 1.3039 0.2799 0.9068 0.2749
rs2738454 1.3720 0.7667 2.0649 0.6117
rs2738455 1.5490 0.7928 2.2572 0.4317
19:11235247 1.7311 1.4309 0.6046 2.3629
rs8106324 1.1772 0.9370 0.2875 1.9936
rs6511724 1.5654 0.0920 1.9689 0.2419
rs75090161 0.6922 0.7608 0.4939 2.2911
rs17242586 0.6864 0.7536 0.4904 2.2829
rs2738457 1.5639 0.7990 2.2330 0.4223
rs2569539 1.5293 0.8141 2.2363 0.4221
rs2569538 0.7753 1.6353 0.4408 2.1744
15
Target LEH LHP REH RHP
Gene Locus/SNP L fL sgL afL our -log(P) L fL sgL afL our -log(P) L fL sgL afL our -log(P) L fL sgL afL our -log(P)
rs2738460 1.5121 0.8278 2.2257 0.4269
rs2304182 1.0312 0.9552 0.9917 0.4033
rs2304181 1.0317 0.9557 0.9915 0.4038
19:11239179 1.0319 0.9558 0.9918 0.4039
rs2738461 2.0453 0.3906 2.7303 0.0079
19:11241428 0.2734 0.6702 0.4377 0.3168
rs6413504 0.3292 0.9297 2.5425 0.4233
rs2738464 0.2217 0.6842 1.1857 2.1186
19:11243209 0.6225 0.9295 0.2573 0.8486
rs2915966 1.0703 1.2712 3.3284 3.5090
rs2978615 0.7032 0.6522 3.5269 0.1348
rs55903358 1.1494 1.2808 1.1002 0.7609
rs5742911 1.1742 0.9523 2.0696 0.5010
GAPDHS
(4/22)
rs4806174 0.2598 1.0513 0.2754 1.1987
19:36025093 0.2992 0.4710 0.2326 1.6105
rs56408696 0.9017 0.6562 0.4423 0.3527
rs2239942 0.5671 0.6892 0.4964 0.3936
BCAM
(15/15)
rs2927477 2.9703 2.4167 1.3773 1.5632
19:45314324 0.0843 0.6623 0.5233 0.6993
rs7249750 2.3677 2.3502 0.6967 2.1090
19:45316223 2.4536 2.4857 0.5994 2.1266
19:45316330 2.3901 2.3522 0.7109 2.1061
rs3810141 2.4601 2.3565 0.7596 2.0953
rs3810140 2.4619 2.3571 0.7608 2.0957
rs2968180 2.8369 2.6676 1.1770 1.8398
rs111548706 3.1791 2.8133 1.1721 2.4296
rs1135062 0.8673 0.3313 0.8898 1.2600
rs3669 1.2158 0.6184 1.8555 1.9138
19:45323170 1.9457 1.3567 2.7893 1.1368
rs28399635 0.6250 0.0077 0.4227 0.4519
rs28399637 5.0766 3.2757 4.3394 2.3330
rs7026 0.3977 0.9759 0.5455 0.4153
PVRL2
(50/164)
rs3810143 0.0568 0.8739 0.3196 0.0028
rs2306149 0.1418 0.5509 0.9558 2.3000
rs2972569 0.0584 1.2822 0.5123 1.6298
rs12974942 0.1161 0.7548 0.5622 0.0219
rs2927469 0.0391 1.0026 0.0150 1.5720
rs2972559 0.9573 0.2427 2.5134 0.1028
rs73050205 0.8887 0.2616 2.5143 0.0707
19:45356752 1.4015 0.1564 1.9717 0.1591
rs35396326 1.0228 0.1839 2.5206 0.1790
rs4803763 0.8644 0.2685 2.5142 0.0689
rs4803764 0.8732 0.2684 2.5132 0.0650
rs56317818 0.8706 0.2718 2.6255 0.0575
rs12462573 0.8266 0.3009 2.5528 0.0374
rs2972557 0.5298 3.5104 0.5427 3.9294
rs12463239 1.2425 1.6314 0.0343 0.9865
rs8112526 1.1821 3.9210 2.0507 3.9007
rs3852856 2.0895 3.3686 0.4751 1.7649
rs3112439 2.2281 5.5792 3.1366 4.6825
rs3112440 2.0872 5.3410 2.8066 4.8694
rs117877932 0.2718 0.2294 0.6176 0.8290
rs11879589 0.5319 0.0128 0.4140 1.5080
rs3852857 0.5299 0.0128 0.4105 1.5103
rs395908 1.3252 2.5642 1.3123 1.9397
rs4081918 0.5152 0.0067 0.3768 1.5292
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Target LEH LHP REH RHP
Gene Locus/SNP L fL sgL afL our -log(P) L fL sgL afL our -log(P) L fL sgL afL our -log(P) L fL sgL afL our -log(P)
rs79074020 0.5085 0.0178 0.3543 1.5411
19:45376044 1.0236 0.2355 1.2981 0.3052
rs519113 0.4692 2.0154 0.7368 3.2749
rs11671274 0.4626 0.0118 0.2041 1.1249
rs11672399 0.7313 0.0025 0.2237 1.6589
rs369599 0.9638 2.3554 0.3546 0.7190
rs412776 2.8945 5.0184 2.2935 4.3709
19:45379566 0.9902 2.3269 0.3512 0.6856
rs370705 0.9759 2.3138 0.3368 0.6816
rs385982 0.9731 2.3153 0.3374 0.6842
rs11669338 2.1823 2.1362 4.5319 0.6529
rs11673139 2.1823 2.1374 4.5324 0.6545
rs71352237 3.0270 5.5205 2.4615 4.9586
19:45383091 3.0326 5.5073 2.4421 4.9404
rs34224078 3.1238 5.6828 2.5423 5.1330
rs35879138 3.1266 5.6869 2.5450 5.1373
rs11083749 0.1248 0.7118 0.7168 0.6826
rs3745150 0.6945 2.0582 0.7033 0.7161
19:45386467 7.2087 11.4767 12.3805 11.2765
rs12972156 7.4868 13.6269 12.7336 13.2125
rs12972970 7.4876 13.6316 12.7382 13.2184
rs34342646 7.4875 13.6346 12.7429 13.2230
rs283812 7.2167 15.5860 13.8906 15.0706
rs283814 0.5026 1.9275 3.0788 2.8765
rs283815 6.6893 13.1772 11.1796 12.4696
rs6857 7.4645 16.7899 14.5335 17.6298
TOMM40
(15/38)
rs184017 6.5911 13.5901 11.4050 13.1810
rs157580 3.9593 7.0721 9.1044 10.2890
rs2075649 1.0123 2.1800 0.5978 0.7212
rs2075650 7.4179 14.1030 12.8059 13.6997
rs157581 6.6616 13.5959 11.4630 13.2322
rs34095326 5.3435 6.1919 9.9105 6.2489
rs34404554 7.4144 14.0686 12.7886 13.6674
rs11556505 7.4135 14.0612 12.7845 13.6604
rs157582 6.5957 13.5386 11.3573 13.1245
rs59007384 7.6850 15.1743 12.2690 14.6344
rs11668327 6.3772 6.9157 6.7505 4.0387
rs118170342 1.7624 3.1034 2.4722 4.4206
rs35568738 1.0708 0.1818 1.0092 0.4404
rs1160984 1.6633 0.2869 1.2824 0.4915
rs10119 4.1452 9.8079 7.8351 13.0492
APOE
(5/5)
rs440446 3.6625 5.2200 6.0049 6.5638
rs769449 13.1079 22.4118 16.1028 21.0525
rs769450 2.6047 5.6348 2.0373 3.4491
rs429358 13.5662 25.2546 17.9385 25.0369
rs7412 1.8479 3.0122 3.0474 4.6691
APOC1
(14/14)
19:45417632 8.3927 13.3937 10.9990 12.5596
19:45417638 8.3749 13.3586 10.9658 12.5394
rs12691088 3.4966 2.4257 5.5566 1.8214
rs5117 8.8625 15.8799 11.5395 14.7969
rs3826688 2.1575 3.3487 3.6469 2.9339
rs73052335 12.3385 20.4728 15.5834 19.9258
rs3925681 4.8058 7.4320 3.8688 9.8087
rs150966173 0.9923 2.5309 1.6387 3.3859
rs12721046 11.2256 19.1327 14.8090 18.4076
rs12721056 4.1169 7.2385 3.3861 7.9466
17
Target LEH LHP REH RHP
Gene Locus/SNP L fL sgL afL our -log(P) L fL sgL afL our -log(P) L fL sgL afL our -log(P) L fL sgL afL our -log(P)
rs484195 2.8087 4.5296 4.4419 4.0451
19:45421972 3.8770 7.2418 3.9087 7.8283
rs12721051 11.6336 21.6248 15.6163 22.2684
rs1064725 2.2981 2.0402 1.4059 0.3741
APOC4
(7/7)
19:45445860 0.2335 1.3186 0.3865 0.6790
19:45446261 3.8279 9.8048 2.5898 7.7119
19:45446271 0.8625 0.8353 0.9413 1.5025
rs5157 1.1912 0.3194 0.5001 1.2607
rs5158 0.0375 1.5699 0.2380 0.9237
rs1132899 1.2890 0.4523 0.7862 1.4671
rs5167 1.4347 1.8962 0.6398 2.8189
EXOC3L2
(26/88)
19:45715976 3.4808 1.3313 1.0972 2.0754
19:45716192 1.8433 1.4002 0.1588 1.8926
19:45716197 1.7716 0.7414 0.0801 1.4170
19:45716678 0.1425 0.3373 1.2363 0.6786
19:45717615 1.8636 2.4635 0.6285 1.6887
19:45718624 1.8734 2.4718 0.6184 1.6884
19:45719065 0.9007 0.4738 0.3541 0.1623
19:45721596 2.0318 2.5855 0.6111 1.8777
19:45723379 1.1438 0.0876 0.2857 0.8241
19:45724044 1.1222 0.0220 0.0262 0.2408
rs10405194 0.0231 0.2934 1.6704 0.1134
rs10403626 0.0230 0.2930 1.6707 0.1136
rs10409909 0.0228 0.2921 1.6717 0.1143
rs10411314 0.0227 0.2917 1.6720 0.1146
rs10410003 0.0224 0.2912 1.6706 0.1152
rs10410561 0.0208 0.2894 1.6709 0.1160
rs10411743 0.0115 0.2775 1.6718 0.1214
19:45728355 0.0108 0.2767 1.6720 0.1218
rs10412154 0.0100 0.2757 1.6721 0.1223
19:45728440 0.0247 0.2412 1.6836 0.1767
rs346761 0.0045 0.2752 1.6777 0.1237
rs10412614 0.0064 0.2713 1.6725 0.1242
rs346772 0.6101 0.0843 2.8401 0.2026
19:45733782 1.3478 0.2223 0.0059 0.1435
rs8109472 1.4264 0.1452 1.1101 0.1373
rs346750 1.4303 0.1707 1.0525 0.1772
CD33
(16/16)
rs12459419 1.0907 0.4046 1.7706 0.9117
rs2455069 0.8196 0.0588 0.2312 0.1462
rs7245846 0.4353 1.0054 2.1357 1.2773
19:51734857 0.3602 1.1170 2.2893 1.4001
19:51735023 0.7299 0.6667 2.2540 1.2577
rs33978622 0.7307 0.6965 2.2992 1.3059
rs34813869 0.3891 1.1139 2.4610 1.5210
rs1354106 0.3100 1.2263 2.4395 1.5045
rs35112940 1.3723 0.7697 1.9413 1.2327
rs10409348 0.3210 2.0647 4.0526 2.8254
rs146995981 0.2094 0.0575 0.3913 0.1173
rs1399839 0.0542 0.9633 1.5430 0.6127
rs273653 0.0476 0.9540 1.5763 0.5891
rs273652 0.1969 0.5591 3.6421 0.6791
rs75773078 1.9834 1.2255 0.0023 0.1933
rs1803254 0.5649 0.6272 2.8029 0.0603
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